Table 1.
Characteristics of patients enrolled in prospective pilot study
| Age (mean ±SD) | 44 ±14 years |
|---|---|
| Male |
62% |
|
Race/ethnicity: | |
| Caucasian |
69% |
| Indian subcontinent |
11% |
| Other |
20% |
| Missing |
0% |
|
Cause of ESRD: | |
| Glomerular |
25% |
| Polycystic disease |
18% |
| Other known |
51% |
| Unknown |
6% |
| Missing |
0% |
| Family history of diabetes |
20% |
|
BMI: | |
| Mean ±SD |
28 ±5 |
| ≤30 |
70% |
| >30 |
30% |
| Missing |
0% |
| Preemptive transplantation |
27% |
| Hemodialysis |
46% |
| Peritoneal dialysis |
27% |
| Zero PRA (%) |
82% |
| 1 to 20% PRA |
18% |
| >20% PRA |
0% |
| Missing |
0% |
|
HLA mismatch: | |
| 1 to 2% |
51% |
| 3 to 6% |
49% |
| Missing |
0% |
| Number of pre-transplant anti-hypertensive medication: | |
| 0 |
33% |
| 1 |
31% |
| >1 |
26% |
|
Total cholesterol: | |
| <5.2 mmol/l |
78% |
| ≥5.2 mmol/l |
22% |
| Living donor |
96% |
|
Pre-transplant 75-gOGTT: | |
| Impaired |
22% |
| Normal | 78% |
BMI, body mass index; ESRD, end stage renal disease; OGTT, oral glucose tolerance test; PRA, panel reactive antibody; SD, standard deviation.